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Abstract
Background: Heterogeneity in malaria exposure complicates survival analyses of vaccine efficacy trials and confounds the
association between immune correlates of protection and malaria infection in longitudinal studies. Analysis may be
facilitated by taking into account the variability in individual exposure levels, but it is unclear how exposure can be
estimated at an individual level.
Method and Findings: We studied three cohorts (Chonyi, Junju and Ngerenya) in Kilifi District, Kenya to assess measures of
malaria exposure. Prospective data were available on malaria episodes, geospatial coordinates, proximity to infected and
uninfected individuals and residence in predefined malaria hotspots for 2,425 individuals. Antibody levels to the malaria
antigens AMA1 and MSP1142 were available for 291 children from Junju. We calculated distance-weighted local prevalence
of malaria infection within 1 km radius as a marker of individual’s malaria exposure. We used multivariable modified Poisson
regression model to assess the discriminatory power of these markers for malaria infection (i.e. asymptomatic parasitaemia
or clinical malaria). The area under the receiver operating characteristic (ROC) curve was used to assess the discriminatory
power of the models. Local malaria prevalence within 1 km radius and AMA1 and MSP1142 antibodies levels were
independently associated with malaria infection. Weighted local malaria prevalence had an area under ROC curve of 0.72
(95%CI: 0.66–0.73), 0.71 (95%CI: 0.69–0.73) and 0.82 (95%CI: 0.80–0.83) among cohorts in Chonyi, Junju and Ngerenya
respectively. In a small subset of children from Junju, a model incorporating weighted local malaria prevalence with AMA1
and MSP1142 antibody levels provided an AUC of 0.83 (95%CI: 0.79–0.88).
Conclusion: We have proposed an approach to estimating the intensity of an individual’s malaria exposure in the field. The
weighted local malaria prevalence can be used as individual marker of malaria exposure in malaria vaccine trials and
longitudinal studies of natural immunity to malaria.
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Introduction
Spatial heterogeneity in malaria exposure has been described at
a micro-epidemiological level at varying transmission settings
[1,2]. It is responsible for variations in disease risk within a small
area and is evidenced by geographical clustering of malaria
infections. Approximately 80% of transmission occurs within 20%
of the population [3,4]. It has been attributed to factors such as
varying ecologies of local malaria vectors[5], the pattern of contact
between human host and vectors and intrinsic human host factors
[6,7].
Heterogeneity in malaria exposure may bias estimates of
malaria vaccine efficacy over time in longitudinal studies [8,9].
This is predicted by simulations of populations under heteroge-
neous malaria exposure, where vaccine efficacy is underestimated
as a consequence of heterogeneity and apparent waning of efficacy
over time is seen even if vaccine protection is maintained [10].
Although a randomized controlled trial may ensure equal
distributions of malaria exposure at the start of the trial, if the
vaccine is protective then the more highly susceptible individuals
will experience earlier clinical malaria episodes in the control
group than in the active vaccination group. Their subsequent
removal from the ‘‘at risk set’’ will subsequently unsettle the
comparability of vaccinees and non-vaccinees and produce
inaccurate estimates of efficacy [8,9]. This effect will become
more marked as time since randomization increases. Furthermore
vaccine efficacy may vary according to the intensity of exposure
[11] and so estimating individual malaria exposure levels would
allow an assessment of the interaction between vaccine effects and
exposure.
Field studies investigating immunity to malaria face similar
challenges to those encountered in vaccine trials. In such studies,
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groups of positive and negative individuals for a particular
immunological variable at baseline are compared using relative
risk estimate for an episode of malaria[12]. However, heteroge-
neity in malaria exposure makes it difficult to ascertain whether
individuals who remain uninfected during the follow up have been
exposed or not [13]. Inclusion of unexposed individuals in the
analysis may result in a bias towards reduced estimates of
immunity to malaria. Several approaches to circumvent this
problem have been suggested. Individuals who develop neither a
febrile episode nor asymptomatic parasitaemia during follow up
might be considered unexposed. Exclusion of these unexposed
individuals from the analysis strengthens the ascertainment of the
effects of immunity, transmission intensity and age [14]. However
the choice of individual exposure marker remains a challenge. Use
of a positive blood film at a single time point may be inaccurate
and could misclassify those whose parasitaemia had been cleared
by anti-malaria drugs or immunity. Furthermore this approach
does not take into account varied degrees of exposure levels. Some
studies have used individual antibodies to schizont extracts as a
marker of exposure [15,16] or other recombinant malaria
antigens[17]. This approach is validated as a marker of exposure
at a population level [18], but at an individual level is complicated
by variations in an individual’s capacity to make antibodies to
specific antigens and saturation effect of antibodies [13,19].
Several statistical models have been proposed to adjust for
heterogeneity of exposure [9,20], but most are difficult to interpret
since they are based on assumed distributions of malaria exposure
within the population. It is not clear how to estimate an
individual’s level of exposure in the field. Entomological
Inoculations Rates, parasite rates and infant conversion rates have
frequently been used to describe exposure at the level of
population, but are not readily applied to individuals.
The objective of this work was to examine alternative
approaches to estimating individual exposure to malaria. We
reasoned that the level of exposure to malaria can be inferred by
proximity to other infected individuals at the local level. We
therefore used data from three cohorts in Kilifi District to
determine the relationship between the risk of malaria infection
and measures such as; proximity to the next nearest infected and
uninfected individual or the number of infected individuals in an
area of a given radius. We also assessed the relationship between
individual AMA1 and MSP1142 antibody levels and risk of malaria
infection in a subset of children from one of the cohorts. We then
determined the performance of these measures in correctly
predicting cases of malaria infection.
Methods
Cohort population and data
We used cohort data from Chonyi, Junju and Ngerenya sub-
locations located within Kilifi Health and Demographic Surveil-
lance System (HDSS) [21]. The data were prospectively collected
between 1999 and 2001 for Chonyi, 1998 and 2010 for Ngerenya
and 2006 and 2010 for the Junju cohort.
Surveillance methods and detailed information on the cohorts
have been previously published [22,23]. In brief, participants were
randomly selected from the study areas. Both weekly active
surveillance by trained field workers and passive surveillance at
health facilities were used to identify clinical malaria episodes.
Blood smears were done in individuals with either a history of
fever (For a Chonyi and Ngerenya cohorts only) or axillary
temperature of 37.5 or more (All three cohorts). A cross sectional
blood smear was done before long rains in all individuals
regardless of the fever. In 291 children aged 5 to 17 months from
the Junju cohort, a venous blood sample was obtained at a single
cross sectional bleed and tested for anti-merozoite surface protein-
1 (MSP-142) and anti-apical membrane antigen-1 (AMA-1) human
immunoglobulin (Ig) G antibodies by enzyme-linked immunosor-
bent assay as described previously [24]. Additional data collected
included individual homestead locations (GIS coordinates).
For the purpose of this study, malaria infection was defined as
any P. falciparum positive blood smears (i.e. either asymptomatic
parasitaemia or an episode of febrile malaria). We also determined
if each individual was living within a malaria hotspot [25]. Chonyi
has been considered as a relatively high malaria transmission area
with Junju and Ngerenya regarded as moderate and low malaria
transmission areas respectively [26]. However since 1999 malaria
has been declining in the overall study area [27].
Assessing the relationship between malaria infection and
proximity to infected case
We computed distances (in Kilometers) from each individual to
all others in each of the cohort. The proximity of the index child to
the next nearest infected child and next nearest uninfected child was
calculated. This was done separately for two time windows; four
months and one year time intervals. To derive the best powers for
transforming distances, we fitted a set of power functions of distance
as a function of malaria infection status in logistic regression models
to optimize the log likelihood. This allowed for a nonlinear
relationship to be fitted. The power functions that maximized the
log likelihood fit were then used to transform absolute distances, and
subsequently used in modified Poisson regression models to assess
the effect of proximity to infected/uninfected children on the risk of
malaria infection in the index child.
Calculation of weighted local prevalence of malaria
infection
The weighted local prevalence was calculated as distance-
weighted proportions of malaria infected children within an area
of specified radius and over specified time intervals. The time
intervals used were four months and one year, in order to assess
the temporal aspect of exposure. The four month interval reflected
three distinct seasons with varying malaria transmission [28] whilst
the one year time interval was selected as a convenient annual
summary. We used inverse distance weighting to give the children
nearest to the index more weight in determining the local
prevalence [29].
x~
PN
i~1
Zi7Di
PN
i~1
17Dið Þ
Where x is the interpolated weighted local malaria prevalence
for the index individual, Zi is the known infection status of the
surrounding child (0: for uninfected and 1: for infected), Di is the
distance from the index individual to the surrounding child. The
weighted local prevalence was expressed as a proportion with
values between 0 and 1. We also calculated unweighted local
malaria prevalence as the simple proportion of infected children
within 1 km.
Selection of best radius
To determine the best radius over which the weighted local
prevalence should be calculated, we grouped children around each
Individual Malaria Exposure in the Field
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index child in the cohort into annuli at #0.2 km, .0.2 km to
#0.5 km, .0.5 km to #1 km and .1 km to #2 km. We then
determined how well the calculated weighted local prevalence
from these annuli predicted the risk of individual malaria infection.
The annuli analyses allowed us to determine if the individuals in
the outer zones had any additional impact in the risk prediction.
The cut-off point for the radius was based on the last distance
beyond which the weighted local prevalence didn’t predict risk of
infection.
Univariate analysis
The outcome measure was binary; malaria infection (i.e. either
asymptomatic parasitaemia or at least one febrile malaria episode)
or no malaria infection (i.e. no asymptomatic parasitaemia and no
febrile malaria episodes) within four months or within one year
time intervals. We investigated the effect of the following variables;
weighted local malaria prevalence, distance to the next nearest
infected and uninfected children and age. Residence in malaria
hotspot as a binary variable was also included in the analysis
because of prior report of its effect on risk of malaria infection
[25]. A malaria hotspot was defined as an area where the observed
incidence of febrile malaria or asymptomatic parasitaemia was
higher than would be expected if cases were evenly distributed, as
defined using the spatial scan statistic at p,0.05, including a
maximum of 30% of the population in a hotspot.
In 291 children from Junju, the effect of log transformed AMA1
and MSP1 antibody levels on malaria infection were also assessed.
The effect of each variable was assessed by modified Poisson
regression analyses with a robust error variance [30].
Multiplicative interaction models were used to assess interac-
tions between proximity to the infected and uninfected children on
the risk of malaria infection in the index child. Adjustments were
made for the multiple observations per individual with a fixed
effect for the time period and random effect term for individual.
Risk Ratios (RR) and 95% confidence intervals (95% CIs) were
derived. To visualize the relationship between risk of malaria
infection in the index child and proximity to other infected and
uninfected children we differentiated the modified Poisson
equation for the effect of distance and plotted the rate of change
in risk over the first 1 km.
Multivariable analysis and model calibration
A multivariable modified Poisson regression model was used to
evaluate the independent role of each variable to predict malaria
infection in the index child by including all significant variables
(p,0.05) of univariate analysis.
We also used causal directed acyclic graph (DAG) as described
before [31] to assess the suitability of our covariates for use in the
final multivariable model. The aim was to minimize the
magnitude of bias for the estimates of local malaria prevalence
on the risk of malaria infection.
To evaluate the discriminatory ability of weighted local malaria
prevalence and log transformed AMA1 and MSP1 antibody levels
for malaria infection in the index child the area under the receiver
operating characteristic (ROC) curve was determined [32]. The
discriminatory power of individual models was compared with the
model consisting of both anti-merozoite antibody levels and
weighted local prevalence. Analyses were done using STATA
version 11 software (Stata Corp., College Station, TX).
Ethical consideration
Written informed consent was obtained from the adults enrolled
and from parents/guardians of the young children enrolled using
an approved consent form. The approval for human participation
in three cohorts was given by the Kenya Medical Research
Institute (KEMRI) National Ethical Review committee [23,33].
Results
A total of 2,425 participants were included in the final analysis
constituting 7,166 person years of follow up. The age of
participants ranged between 0 to 81 years (median 15, IQR; 0–
76.2). There were 10,304 confirmed malaria infections of which
6,377 (62%) were asymptomatic. The demographic, parasitolog-
ical characteristics and duration of follow-up for the three cohorts
is shown in table 1.
Risk of malaria as a function of proximity to the infected
case
Increasing distance to the next nearest infected child was
associated with a reduced risk of malaria infection in the index
child in all three cohorts (RR=0.37, 95%CI: 0.28–0.50 for Junju,
RR=0.18, 95%CI 0.03–0.84 for Chonyi and RR=0.52, 95%CI
0.42–0.66 for Ngerenya). The rate of change in risk was highest
within 1 km (Figure S1).
In contrast increasing distance to the next nearest uninfected
child was associated with an increased risk of malaria infection in
the index child; RR of 1.88 (95%CI: 1.30–2.72), 1.72 (95%CI:
1.48–2.0) and 1.49 (95%CI: 1.35–1.65) in Chonyi, Junju and
Ngerenya respectively. The rate of change in risk was similarly
highest within the first 1 km (Figure S1). We identified no
interaction between the effects of distance to infected and
uninfected children on the risk of malaria infection in the index
child.
Risk of malaria as a function of the weighted local malaria
prevalence within a 1 km radius
The values of weighted local prevalence ranged between 0 and
1 and their distributions are shown in Figure S2. In Junju and
Chonyi, weighted local malaria prevalence estimated from
participants within #0.2 km, .0.2 km to #0.5 km, .0.5 km to
#1 km but not those within .1 km to #2 km zones were
predictive of malaria infection in the index child. In Ngerenya
weighted local malaria prevalence estimated from participants
within all four annulus were predictive of malaria infection in the
index child (Table 2). We reasoned that because there was in
inconsistent effect on the risk of malaria infection by the weighted
local malaria prevalence beyond 1 km, but a consistent effect for
the three zones examined within 1 km, that the optimal measure
of exposure would be the distance-weighted proportion of malaria
infections within 1 km radius. Consistently the plots of rate of
change in risk of malaria infection versus proximity to infected
case showed only a marginal effect beyond 1 km in all three
cohorts (Figure S1).
In a univariate analysis, weighted local malaria prevalence
within 1 km was a strong predictor of risk of malaria infection in
the index child in all three cohorts. An increase of 10% in
weighted local malaria prevalence resulted in malaria infection
RR of 1.99(95%CI: 1.75–2.26), 2.19(95%CI: 1.77–2.70) and 2.25
(95%CI: 1.90–2.67) in Junju, Chonyi and Ngerenya cohort
respectively. Areas under the ROC curve for the univariate
weighted local malaria prevalence models were 0.72(95%CI:
0.66–0.73), 0.71(95%CI: 0.69–0.73), and 0.82 (95%CI: 0.80–0.83)
for Chonyi, Junju, and Ngerenya respectively.
The effect of unweighted local malaria prevalence was similar to
weighted local prevalence with a tendency towards higher areas
under ROC curve for distance-weighted than unweighted local
malaria prevalence (Table 2).
Individual Malaria Exposure in the Field
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We also examined the effects of weighted local malaria
prevalence estimated from quarterly follow up data. These did
not differ significantly from those estimated from yearly follow up
data in Junju and Chonyi but was significantly higher in Ngerenya
cohort (Table S1). The Areas under ROC curve were similar to
those of yearly follow up in all the cohorts.
Effect of malaria hotspot and age on the risk of malaria
infection
Residence in a malaria hotspot was associated with an increased
risk of malaria infection in the index child. The effect was more
pronounced in the lowest transmission area; Ngerenya (RR: 1.45,
95%CI: 1.35–1.55) than in areas of moderate to high malaria
transmission; Junju (RR; 1.29, 95%CI: 1.19–1.41) and Chonyi
(RR: 1.23, 95%CI: 1.15–1.32) respectively. Age had a statistically
significant non-linear effect on malaria infection in the index child.
In all three cohorts risk of malaria infection increased with age and
peaked at 5 years before starting a slow decline (Figure S3).
Multivariable models for predicting risk of malaria
infection
Multivariable models were separately developed for the three
cohorts to assess the independent role of predictors of malaria
infection in the index child and to determine the overall
discrimination achieved with the multivariable model. The final
multivariable model incorporated the weighted local malaria
Table 1. Demographic and parasitological characteristics of the cohorts used in the analysis.
Cohorts Junju Chonyi Ngerenya
Follow up period 2006 to 2010 1999–2000 1998–2010
Age (median, IQR) 3.1(0.1–6.4) 15.6 (0.1–78.9) 14.5 (0–80)
Number of all participants (Percentage below 10 years) 620 (100) 874 (61.6) 931(66.9)
Female % 48.4% 58.7% 56%
Total number of malaria infections 2109 3283 4912
Asymptomatic infection 408 2480 3489
Total surveillance visits 83,566 90,437 200,074
Mode of surveillance Active surveillance Active surveillance Active surveillance
doi:10.1371/journal.pone.0032929.t001
Table 2. Effect of weighted local prevalence of malaria infection from four annuli around each individual on risk of malaria
infection.
RR(95%CI) P value AUC*
Chonyi cohort
Weighted local malaria prevalence(,0.2 km) 2.19(1.78–2.70) ,0.001 0.68
Weighted local malaria prevalence (.0.2–0.5 km) 2.23 (1.66–3.02) ,0.001 0.68
Weighted local malaria prevalence (.0.5–1 km) 1.80 (1.279–2.55) 0.001 0.67
Weighted local malaria prevalence (.1–2 km) 1.49 (0.95–2.33) 0.079 NA
Unweighted local malaria prevalence,1 km 3.36 (1.66–6.77) 0.001 0.65
Weighted local malaria prevalence ,1 km 2.19 (1.78–2.70) ,0.001 0.68
Junju cohort
Weighted local malaria prevalence(,0.2 km) 1.95 (1.71–2.22) ,0.001 0.71
Weighted local malaria prevalence (.0.2–0.5 km) 1.42 (1.15–1.74) 0.001 0.68
Weighted local malaria prevalence (.0.5–1 km) 1.99 (1.22–3.24) 0.005 0.68
Weighted local malaria prevalence (.1–2 km) 0.71 (0.33–1.52) 0.383 NA
Unweighted local malaria prevalence,1 km 1.54 (1.18–2.01) 0.001 0.67
Weighted local malaria prevalence ,1 km 1.99 (1.75–2.26) ,0.001 0.71
Ngerenya cohort
Weighted local malaria prevalence(,0.2 km) 2.25 (1.90–2.67) ,0.001 0.82
Weighted local malaria prevalence (.0.2–0.5 km) 0.97 (0.69–1.36) 0.887 NA
Weighted local malaria prevalence (.0.5–1 km) 1.81 (1.44–2.27) ,0.001 0.81
Weighted local malaria prevalence (.1–2 km) 1.52 (1.13–2.04) 0.005 0.79
Unweighted local malaria prevalence,1 km 3.38 (2.58–4.42) ,0.001 0.80
Weighted local malaria prevalence ,1 km 2.25 (1.90–2.67) ,0.001 0.82
*AUC: Area under the curve.
doi:10.1371/journal.pone.0032929.t002
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prevalence within a 1 km radius, distance to the next nearest
infected child, distance to the next nearest uninfected child, age
and whether resident in a malaria hotspot. Using DAG approach
we confirmed that all selected covariates were plausible confound-
ers and their inclusion in the final model would minimize the
magnitude of the bias in the estimate of effect of local malaria
prevalence on the risk of malaria infection (Figure S4).
Weighted local malaria prevalence, location within a malaria
hotspot and age remained significant predictors of malaria
infection in the multivariable model (Table 3). Proximity to the
nearest infected child was predictive in Chonyi but not in Junju
and Ngerenya. The areas under the ROC curve for the
multivariable prediction models were 0.74 (95%CI: 0.72–0.76)
0.72 (95%CI: 0.70–0.74), and 0.84 (95%CI: 0.83–0.85) for the
Chonyi, Junju, and Ngerenya cohorts, respectively (Figure 1).
Local malaria prevalence and Merozoite antibodies based
models in predicting malaria risk
Merozoite antibody levels were assessed in 291 children in the Junju
cohort (median age 20.5 months, IQR: 11.6–28.1) at a cross sectional
bleed. Merozoite antibodies levels were associated with increase in
prospective risk of malaria infection in the index child (Table 4).
Univariate predictive models for AMA-1 and MSP-142 antibodies
produced areas under the ROC curve of 0.75 and 0.76 respectively.
In the same group of children weighted local malaria prevalence
within 1 km radius was associated with the risk of malaria in the
index child in the univariate model providing area under ROC
curve of 0.69 (95%CI: 0.64–0.73). A multivariable model
incorporating weighted local malaria prevalence, distance to the
next nearest infected, distance to the next nearest uninfected
children and residence in a malaria hotspot had an area under the
ROC curve of 0.72 (95%CI: 0.67–0.76) which was not markedly
different from either weighted local malaria prevalence or
antibody level specific univariate models. The area under the
ROC curve for the multivariable model incorporating weighted
local malaria prevalence and antibodies to AMA1 and MSP142
was 0.83 (95%CI: 0.79–0.88) (Table 4).
Discussion
Being able to quantify an individual’s malaria exposure in the
field will allow a more precise analysis of the efficacy of candidate
malaria vaccines in clinical trials, and of the potential immune
correlates associated with protection from malaria. Based on this
study we propose a measure of individual malaria exposure that
uses the distance-weighted local prevalence of malaria infection
(composite endpoint including asymptomatic infection or febrile
malaria) within a 1 km radius. The measure is empirical, being
derived from active malaria surveillance and location data, and
Table 3. Univariate and Multivariable analysis of predictors of malaria infections.
Univariate analysis Multivariable analysis
RR(95% CI P value RR (95% CI P value
Chonyi cohort
Weighted local prevalence (1 km radius)1 2.19(1.77–2.70) ,0.001 1.78(1.38–2.29) ,0.001
Proximity to nearest infected case1 0.18 (0.03–0.84) 0.03 0.33(0.07–1.40) 0.135
Proximity to the second nearest case1 1.07(0.65–1.76) 0.763 NA#
Proximity to the nearest uninfected case1 1.88(1.30–2.72) 0.001 1.13(0.78–1.65) 0.499
Proximity to the second nearest uninfected case1 0.93(0.72–1.21) 0.619 NA# -
Residence in malaria hotspot 1.23(1.15–1.32) ,0.001 1.14(1.06–1.22) ,0.001
Age (years)* NA ,0.001 NA ,0.001
Junju cohort
Weighted local prevalence (1 km radius)1 1.99(1.75–2.26) ,0.001 1.51(1.21–1.87) ,0.001
Proximity to nearest infected case1 0.37(0.28–0.50) ,0.001 0.57(0.40–0.81) 0.002
Proximity to the second nearest case1 0.74(0.62–0.87) ,0.001 NA# -
Proximity to the nearest uninfected case1 1.72(1.48–2.0) ,0.001 1.16(0.93–1.43) 0.172
Proximity to the second nearest uninfected case1 1.63(1.40–1.90) ,0.001 NA# -
Residence in malaria hotspot 1.29(1.19–1.41) ,0.001 1.19(1.10–1.30) ,0.001
Age (years)* NA ,0.001 NA ,0.001
Ngerenya cohort
Weighted local prevalence (1 km radius)1 2.25 (1.90–2.67) ,0.001 1.49(1.24–1.81) ,0.001
Proximity to nearest infected case1 0.52(0.42–0.66) ,0.001 0.52(0.38–0.71) ,0.001
Proximity to the second nearest case1 0.77(0.56–1.05) 0.101 NA#
Proximity to the nearest uninfected case1 1.49(1.35–1.65) ,0.001 1.07(0.93–1.24) 0.286
Proximity to the second nearest uninfected case1 1.42(1.31–1.54) ,0.001 1.17(1.05–1.30) 0.003
Residence in malaria hotspot 1.45(1.35–1.55) ,0.001 1.26(1.16–1.36) ,0.001
Age (years)* NA ,0.001 NA ,0.001
*Multivariable polynomial fraction showed age has a non linear effect in all the cohorts (see Figure S3),
#: The best fit model was obtained with only first nearest distances in the model,
1: Risk ratios are for each step increase in 0.35 and 0.45 power function of distance to the infected and uninfected child respectively.
doi:10.1371/journal.pone.0032929.t003
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not based on any assumed distribution of exposure. The weighted
local malaria prevalence demonstrated moderate to good
discriminatory ability for malaria infection in the index child
(ROC of 0.71, 0.72 and 0.82 in Junju, Chonyi and Ngerenya
respectively). The discriminatory ability of a multivariable model
incorporating the distance-weighted local malaria prevalence
(within a 1 km radius), age, distance to the next nearest infected,
distance to the next nearest uninfected children and the presence
or absence of a malaria hotspot was not statistically different from
that of distance-weighted local prevalence within a 1 km radius
alone (Table 4).
In 291 children in Junju who had antibody levels measured,
merozoite surface protein-1 (MSP-1142) and apical membrane
antigen-1 (AMA-1) antibody levels were also good predictors of the
individual prospective risk of malaria infection as described before
[24,34] and their discriminatory ability for malaria infection was
comparable to that of weighted local malaria prevalence. The
combined model incorporating both of the antibodies data as well
as and the weighted local malaria prevalence had slightly higher
discriminatory ability than either alone (ROC of 0.83). Weighted
local malaria prevalence captures exposure related to the spatial
distribution of local infections. However antibody responses likely
Table 4. Merozoite antibody versus weighted local prevalence based models in predicting malaria infection in a Junju sub-cohort.
RR [95% CI] P value AUC* (95%CI)
Univariate specific antibody-based model
AMA1 2.27 1.80–2.86 ,0.001 0.75 (0.70–0.80)
MSP1142 2.03 1.70–2.42 ,0.001 0.76 (0.72–0.82)
Multivariable weighted local prevalence-based model
Weighted local prevalence 2.29 1.22–4.30 0.009 0.72 (0.67–0.76)
Malaria hotspot 1.16 0.89–1.51 0.245
Proximity to the nearest infected case 0.76 0.43–1.32 0.337
Proximity to the nearest uninfected case 1.08 0.62–1.87 0.768
Univariate weighted local prevalence-based model
Weighted local prevalence 3.00 2.28–3.94 ,0.001 0.69 (0.64–0.73)
Combined weighted local prevalence and anti-merozoite antibody
Weighted local prevalence (1 km) 2.14 (1.60–2.87) ,0.001 0.83(0.79–0.88)
AMA1 1.36 (1.06–1.74) 0.015
MSP1142 1.56 (1.28–1.89) ,0.001
*AUC: Area under the curve.
doi:10.1371/journal.pone.0032929.t004
Figure 1. Areas under the ROC curves for the Multivariable weighted local prevalence based models for the three cohorts.
doi:10.1371/journal.pone.0032929.g001
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reflects both geographical variations in exposure and individual
variations resulting from factors such as bed net use, individual
attractiveness to mosquitoes [6] or genetic variation in suscepti-
bility [35]. This could explain the improved predictive power of
the model incorporating the two measures. However, using
antibody levels as marker of exposure could be circular in
observational studies of natural immunity, particularly when one
intends to assess the potential protective value of same antibody
response or a closely correlated antibody response. Under such
circumstances adjusting for weighted local malaria prevalence as a
marker of exposure may improve the estimates of antibody effect.
Furthermore, antibody levels to blood stage antigens may be
misleading if half the cohort has been randomized to a pre-
erythrocytic vaccine that prevents exposure to blood stage
parasites. On the other hand, provided a standardized assay is
used, antibody levels will be more readily generalized between
cohorts, and give an indication of the average transmission
intensity of the cohort that can be compared with other cohorts.
Heterogeneous exposure to malaria complicates the analysis of
efficacy of candidate malaria vaccines [10]. Calculating the
weighted local prevalence of malaria infection for each child will
allow for more sophisticated analyses, such as dividing the cohort
into ‘‘high exposure’’ and ‘‘low exposure’’ groups, and examining
interactions between intensity of malaria exposure and vaccina-
tion. Other indirect measures of exposure such as entomological
inoculation rate and parasite prevalence may also be used at a
larger scale in large multi-centre study involving sites with known
transmission intensities. However for a single site such measures
will provide only the average exposure for the population and not
reflect the underlying variability of exposure at homestead or
individual level.
To avoid circular reasoning we avoided using index child’s own
malaria infection status to calculate the individual weighted local
malaria prevalence. Our causal diagram proposed additional
cause for malaria hotspot comprising of unmeasured environmen-
tal factors. Therefore, although both local malaria prevalence and
malaria hotspot shared spatial transmission factors as common
ancestor, they represented two different causal pathways to
sporozoites exposure. This could explain why the effect of malaria
hotspot and local malaria prevalence remained significant in the
multivariable model.
The risk of malaria infection (i.e. the composite endpoint of
asymptomatic and symptomatic parasitaemia) increased with age
early on in life and decreased with age later in life consistent with
findings from previous studies [36]. Lower exposure to mosquito
bites due to small body surface area in children could explain the
early trend [37], and the apparent observed decline in the risk of
malaria infection later in life could be attributed to the
development of effective pre-erythrocytic immunity or of blood
stage immunity which suppresses asymptomatic parasitaemia
below the level of detection [38].
Our study has limitations. Our surveillance approach identifies
acute clinical malaria by weekly surveillance and asymptomatic
parasitaemia on yearly cross-sectional blood films. We would
therefore miss brief asymptomatic infections, asymptomatic
infections below the level of detection by microscopy, and
exposure that does not result in a blood stage infection because
of pre-erythrocytic immunity. Nevertheless we have identified here
empiric evidence that weighted local malaria prevalence predicts
the risk of malaria infection in the index child with reasonable
accuracy. We infer that the bias resulting from the limitations
described do not preclude the utility of the approach. Further-
more, these limitations may result in an under-estimate of the local
prevalence of infection, but in the absence of a geographical bias,
the local prevalence will still reflect the intensity of exposure
relative to the rest of the cohort.
Our findings may not be directly applicable to other settings
where the transmitting vectors and human behavior patterns vary.
The optimal radius for calculating local prevalence may be
different, and the relative predictive power of malaria hotspots,
weighted local malaria prevalence and antibody levels would
reflect the local setting. However, heterogeneity on a fine-scale is
observed in many different settings [2,39,40] and it is likely that
our approach to determining weighted local malaria prevalence
could be adapted to these settings given adequate data.
We have assumed that individuals remained in the same
location. Although most infections are likely to be acquired in the
evening or night when individuals are at the homestead, it is
possible that some infections were acquired during travel and this
is not captured in the calculation of the weighted local malaria
prevalence. Finally the described analysis was possible given the
existence of continuous population based surveillance in Kilifi,
something which may not be applicable in other settings.
In conclusion we have used a conceptually straightforward
approach to generate weighted local malaria prevalence as an
estimate of individual’s intensity of exposure to malaria. We have
demonstrated that the weighted local malaria prevalence has
satisfactory discriminatory ability, particularly when combined
with anti-merozoite antibody levels. We propose that it could be
used as general marker of exposure to malaria and used as a
covariate in models assessing the efficacy of potential malaria
vaccines or immune correlates of protection to adjust for the
heterogeneity in malaria exposure.
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Figure S1 Rate of change in risk of malaria infection as
a function of distance to infected and uninfected in the
first Kilometer. Y axis represents a change in risk coefficient
per unit increase in kilometer from infected or uninfected case.
(TIF)
Figure S2 Distribution of weighted local prevalence of
malaria in the three cohorts by year of follow up. * No
case of malaria infection was identified in the Ngerenya cohort
between 2008 and 2010.
(TIF)
Figure S3 Multivariable Fractional polynomial plots of
effect of age on the risk of malaria infection in three
cohorts.
(TIF)
Figure S4 Causal directed acyclic graphs (DAG). Panel A
represents the causal diagram for the data Panel B represent causal
diagram after 6 step DAG approach and if one conditions on Age,
malaria hotspot, spatial transmission factors (distance from
infected and uninfected children) and blood stage antibodies
(dashed boxes). Dotted lines represent conditional associations.
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Table S1 Weighted local prevalence of malaria infection
for four monthly follow-up data. Multivariable polynomial
fraction showed age has a non linear effect in all the cohorts (see
Figure S3).
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